Compare Tata India Pharma & Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
2.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.43
2.11
NAV
₹31.41
₹41.55
Fund Started
04 Dec 2015
25 Jun 2018
Fund Size
₹1386.99 Cr
₹6453.52 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
1 Year
4.79%
5.40%
3 Year
22.25%
26.73%
5 Year
12.91%
15.16%
Equity
99.30%
99.82%
Cash
0.70%
0.18%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.38% |
Healthcare Global Enterprises Ltd. | 5.87% |
Divi's Laboratories Ltd. | 5.80% |
Abbott India Ltd. | 5.41% |
Cipla Ltd. | 5.18% |
Max Healthcare Institute Ltd. | 4.80% |
Apollo Hospitals Enterprise Ltd. | 4.56% |
Rainbow Children's Medicare Ltd. | 4.52% |
Dr. Reddy's Laboratories Ltd. | 4.02% |
Mankind Pharma Ltd. | 3.77% |
Sun Pharmaceutical Industries Ltd. | 12.09% |
Dr. Reddy's Laboratories Ltd. | 7.70% |
Cipla Ltd. | 7.45% |
Mankind Pharma Ltd. | 7.03% |
Divi's Laboratories Ltd. | 6.06% |
Biocon Ltd. | 4.71% |
Cohance Lifesciences Ltd. | 4.37% |
Alkem Laboratories Ltd. | 4.08% |
Medplus Health Services Ltd. | 3.86% |
Max Healthcare Institute Ltd. | 3.36% |
Name
-
-
Start Date
-
-
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
04 Dec 2015
25 Jun 2018
